Willamette Valley Cancer Center is a clinical research site located in Springfield, Oregon, United States 97477.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Willamette Valley Cancer Center has participated in 8 clinical trials.
Therapeutic areas: Chronic Lymphocytic Leukemia, Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: Gilead Sciences, Morphotek, Novartis Pharmaceuticals.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Willamette Valley Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Willamette Valley Cancer Center has 8 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Ovarian Cancer, Fallopian Tube Cancer.
Yes — Willamette Valley Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.